Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $333000.0.

  • IDEAYA Biosciences' Capital Expenditures fell 6978.22% to $333000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 million, marking a year-over-year decrease of 3860.51%. This contributed to the annual value of $2.4 million for FY2025, which is 3860.51% down from last year.
  • Per IDEAYA Biosciences' latest filing, its Capital Expenditures stood at $333000.0 for Q4 2025, which was down 6978.22% from $42000.0 recorded in Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' Capital Expenditures ranged from a high of $1.8 million in Q2 2022 and a low of $42000.0 during Q3 2025
  • Moreover, its 5-year median value for Capital Expenditures was $663000.0 (2025), whereas its average is $772631.6.
  • As far as peak fluctuations go, IDEAYA Biosciences' Capital Expenditures soared by 293939.39% in 2021, and later plummeted by 9080.96% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Capital Expenditures (Quarter) stood at $605000.0 in 2021, then skyrocketed by 81.98% to $1.1 million in 2022, then dropped by 23.89% to $838000.0 in 2023, then soared by 31.5% to $1.1 million in 2024, then crashed by 69.78% to $333000.0 in 2025.
  • Its Capital Expenditures was $333000.0 in Q4 2025, compared to $42000.0 in Q3 2025 and $663000.0 in Q2 2025.